Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Patient safety is at the forefront of critical issues in health care. Medications are the single most frequent cause of adverse events, and in the inpatient setting adverse drug events (ADEs) are common, expensive, injurious to patients, and often preventable. Relatively little, however, is known about the frequency of ADEs in the ambulatory setting, how to monitor for outpatient ADEs, or on the impact of prevention strategies such as computerization of prescribing supplemented by decision-support.
Specific Aim 1: Increase routine identification of outpatient adverse drug events (ADEs) through development of a computerized ADE detection monitor.
Specific Aim 2: Use basic computerized outpatient prescribing to reduce preventable ADEs in a diverse array of outpatient settings.
Specific Aim 3: Use advanced decision-support within computerized prescribing to reduce the frequency of preventable ADEs, medication errors, and potential ADEs.
Not provided
Not provided
Not provided
Not provided
Not provided
| Label | Type | Description | Intervention Names |
|---|---|---|---|
| Adverse Drug Event Monitoring | Experimental | In this intervention arm, clinicians received medication safety alerts when they prescribed medications in the electronic medical record. |
|
| Care as Usual | No Intervention | In this arm, clinicians did not receive the medication safety alerts. |
| Name | Type | Description | Arm Group Labels | Other Names |
|---|---|---|---|---|
| Adverse Drug Event Monitoring | Other | The intervention in this study is the presentation of medication safety alerts in the electronic medical record to improve patient outcomes and safety. |
| Measure | Description | Time Frame |
|---|---|---|
| Preventable Adverse drug events | Data were electronically collected each time a physician entered a prescription that triggered an alert related to medication safety. | 8/5/2004 - 1/5/2005 |
| Measure | Description | Time Frame |
|---|---|---|
| Total adverse drug events, medication errors | 1/15/2001 - 5/15/2001 |
Not provided
Inclusion Criteria: At Brigham & Women's Hospital, clinics utilizing the electronic medical record will be included. At Regenstrief, any clinic that has access to their electronic medical record will be utilized.
Exclusion Criteria:
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
| Name | Affiliation | Role |
|---|---|---|
| Tejal K Gandhi, MD, MPH | Brigham and Women's Hospital | Study Director |
| David Bates, MD | Brigham and Women's Hospital | Principal Investigator |
| Marc Overhage, MD | Regenstrief Institute, Inc. | Study Director |
| Facility | Status | City | State | ZIP | Country | Contacts |
|---|---|---|---|---|---|---|
| Regenstrief/Indiana University | Indianapolis | Indiana | United States | |||
| Brigham and Women's Hospital |
| PubMed Identifier | Type | Citation | Retractions |
|---|---|---|---|
| 16221941 | Result | Shah NR, Seger AC, Seger DL, Fiskio JM, Kuperman GJ, Blumenfeld B, Recklet EG, Bates DW, Gandhi TK. Improving acceptance of computerized prescribing alerts in ambulatory care. J Am Med Inform Assoc. 2006 Jan-Feb;13(1):5-11. doi: 10.1197/jamia.M1868. Epub 2005 Oct 12. | |
| 22130350 | Result | Gandhi TK, Seger AC, Overhage JM, Murray MD, Hope C, Fiskio J, Teal E, Bates DW. Outpatient adverse drug events identified by screening electronic health records. J Patient Saf. 2010 Jun;6(2):91-6. doi: 10.1097/PTS.0b013e3181dcae06. |
| Label | URL |
|---|---|
| Related Info | View source |
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
| Boston |
| Massachusetts |
| 02115 |
| United States |